nach oben

Journal of Gastrointestinal Surgery

Erschienen in:

07.06.2021 | Review Article

Association Between Anesthesia Delivered During Tumor Resection and Cancer Survival: a Systematic Review of a Mixed Picture with Constant Themes

verfasst von: Luke V. Selby, Ana Fernandez-Bustamante, Aslam Ejaz, Ana Gleisner, Timothy M. Pawlik, David J. Douin

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Surgery is required for cure of most solid tumors, and general anesthesia is required for most cancer surgery. The vast majority of cancer surgery is facilitated by general anesthesia using volatile inhalational agents such as isoflurane and sevoflurane. Only recently have the immunologic and oncologic effect of inhalational agents, and their alternative, propofol-based total intravenous anesthesia (TIVA), come under investigation.

Methods

Between January 2019 and June 2020, English language articles on PubMed were searched for the keywords “Propofol” “TIVA” or “IV anesthesia” and either “cancer surgery” or “surgical oncology.” Duplicates were removes, manuscripts classified as either in vitro, animal, translational, or clinical studies, and their results summarized within these categories.

Results

In-vitro and translational data suggest that inhalational anesthetics are potent immunosuppressive and tumorigenic agents that promote metastasis, while propofol is anti-inflammatory, anti-tumorigenic, and prevents metastasis development. Clinically there is a recurring association, based largely on retrospective, single institution series, that TIVA is associated with significant improvements in disease-free interval and overall survival in a number of, but not all, solid tumors. The longer the surgery is, the more intense the surgical trauma is, the more aggressive the malignancy is, and the higher likelihood of an association is.

Discussion

Prospective randomized trials, coupled with basic science and translational studies, are needed to further define this association.

Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B, Global Onco-Anesthesia Research Collaboration G. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 2019;66(5):546-61. doi:https://doi.org/10.1007/s12630-019-01330-x.CrossRefPubMed

Perry NJS, Buggy D, Ma D. Can anesthesia influence cancer outcomes after surgery? JAMA surgery. 2019;154(4):279-80. doi:https://doi.org/10.1001/jamasurg.2018.4619.CrossRefPubMed

Hiller JG, Perry NJ, Poulogiannis G, Riedel B, Sloan EK. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2018;15(4):205-18. doi:https://doi.org/10.1038/nrclinonc.2017.194.CrossRefPubMed

Dubowitz JA, Sloan EK, Riedel BJ. Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis. Clin Exp Metastasis. 2018;35(4):347-58. doi:https://doi.org/10.1007/s10585-017-9862-x.CrossRefPubMed

Dillekås H, Demicheli R, Ardoino I, Jensen SAH, Biganzoli E, Straume O. The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. Breast Cancer Res Treat. 2016;158(1):169-78. doi:https://doi.org/10.1007/s10549-016-3857-1.CrossRefPubMedPubMedCentral

Tohme S, Simmons RL, Tsung A. Surgery for cancer: a trigger for metastases. Cancer research. 2017;77(7):1548-52. doi:https://doi.org/10.1158/0008-5472.Can-16-1536.CrossRefPubMedPubMedCentral

Sessler DI, Riedel B. Anesthesia and cancer recurrence: context for divergent study outcomes. Anesthesiology. 2019;130(1):3-5. doi:https://doi.org/10.1097/ALN.0000000000002506.CrossRefPubMed

Yoo S, Lee HB, Han W, Noh DY, Park SK, Kim WH et al. Total intravenous anesthesia versus inhalation anesthesia for breast cancer surgery: a retrospective cohort study. Anesthesiology. 2019;130(1):31-40. doi:https://doi.org/10.1097/ALN.0000000000002491.CrossRefPubMed

Huang WW, Zhu WZ, Mu DL, Ji XQ, Nie XL, Li XY et al. Perioperative management may improve long-term survival in patients after lung cancer surgery: a retrospective cohort study. Anesthesia and analgesia. 2018;126(5):1666-74. doi:https://doi.org/10.1213/ANE.0000000000002886.CrossRefPubMedPubMedCentral

10.

Oh CS, Lee J, Yoon TG, Seo EH, Park HJ, Piao L et al. Effect of equipotent doses of propofol versus sevoflurane anesthesia on regulatory T cells after breast cancer surgery. Anesthesiology. 2018;129(5):921-31. doi:https://doi.org/10.1097/ALN.0000000000002382.CrossRefPubMed

11.

Jun IJ, Jo JY, Kim JI, Chin JH, Kim WJ, Kim HR et al. Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: a retrospective observational study. Sci Rep. 2017;7(1):14020. doi:https://doi.org/10.1038/s41598-017-14147-9.CrossRefPubMedPubMedCentral

12.

Wigmore TJ, Mohammed K, Jhanji S. Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: a retrospective analysis. Anesthesiology. 2016;124(1):69-79. doi:https://doi.org/10.1097/ALN.0000000000000936.CrossRefPubMed

13.

Enlund M, Berglund A, Andreasson K, Cicek C, Enlund A, Bergkvist L. The choice of anaesthetic—sevoflurane or propofol—and outcome from cancer surgery: a retrospective analysis. Ups J Med Sci. 2014;119(3):251-61. doi:https://doi.org/10.3109/03009734.2014.922649.CrossRefPubMedPubMedCentral

14.

Buckley A, McQuaid S, Johnson P, Buggy DJ. Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study. Br J Anaesth. 2014;113 Suppl 1:i56-62. doi:https://doi.org/10.1093/bja/aeu200.CrossRefPubMed

15.

Irwin MG, Chung CKE, Ip KY, Wiles MD. Influence of propofol-based total intravenous anaesthesia on peri-operative outcome measures: a narrative review. Anaesthesia. 2020;75 Suppl 1:e90-e100. doi:https://doi.org/10.1111/anae.14905.CrossRefPubMed

16.

Deiner S. Highlights of anesthetic considerations for intraoperative neuromonitoring. Semin Cardiothorac Vasc Anesth. 2010;14(1):51-3. doi:https://doi.org/10.1177/1089253210362792.CrossRefPubMed

17.

Chang YT, Wu CC, Tang TY, Lu CT, Lai CS, Shen CH. Differences between total intravenous anesthesia and inhalation anesthesia in free flap surgery of head and neck cancer. PloS one. 2016;11(2):e0147713. doi:https://doi.org/10.1371/journal.pone.0147713.CrossRefPubMedPubMedCentral

18.

Tang N, Ou C, Liu Y, Zuo Y, Bai Y. Effect of inhalational anaesthetic on postoperative cognitive dysfunction following radical rectal resection in elderly patients with mild cognitive impairment. J Int Med Res. 2014;42(6):1252-61. doi:https://doi.org/10.1177/0300060514549781.CrossRefPubMed

19.

Geng YJ, Wu QH, Zhang RQ. Effect of propofol, sevoflurane, and isoflurane on postoperative cognitive dysfunction following laparoscopic cholecystectomy in elderly patients: a randomized controlled trial. J Clin Anesth. 2017;38:165-71. doi:https://doi.org/10.1016/j.jclinane.2017.02.007.CrossRefPubMed

20.

Ruan D, So SP. Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo. Life Sci. 2014;116(1):43-50. doi:https://doi.org/10.1016/j.lfs.2014.07.042.CrossRefPubMed

21.

Zhou L, Li Y, Li X, Chen G, Liang H, Wu Y et al. Propranolol attenuates surgical stress-induced elevation of the regulatory T cell response in patients undergoing radical mastectomy. J Immunol. 2016;196(8):3460-9. doi:https://doi.org/10.4049/jimmunol.1501677.CrossRefPubMed

22.

Kim R. Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence. J Transl Med. 2018;16(1):8. doi:https://doi.org/10.1186/s12967-018-1389-7.CrossRefPubMedPubMedCentral

23.

Choi JE, Villarreal J, Lasala J, Gottumukkala V, Mehran RJ, Rice D et al. Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study. Cancer Med. 2015;4(6):825-33. doi:https://doi.org/10.1002/cam4.428.CrossRefPubMedPubMedCentral

24.

Grilz E, Mauracher LM, Posch F, Königsbrügge O, Zöchbauer-Müller S, Marosi C et al. Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer. Br J Haematol. 2019;186(2):311-20. doi:https://doi.org/10.1111/bjh.15906.CrossRefPubMedPubMedCentral

25.

Boone BA, Murthy P, Miller-Ocuin J, Doerfler WR, Ellis JT, Liang X et al. Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps. BMC Cancer. 2018;18(1):678. doi:https://doi.org/10.1186/s12885-018-4584-2.CrossRefPubMedPubMedCentral

26.

Jung HS, Gu J, Kim JE, Nam Y, Song JW, Kim HK. Cancer cell-induced neutrophil extracellular traps promote both hypercoagulability and cancer progression. PloS one. 2019;14(4):e0216055. doi:https://doi.org/10.1371/journal.pone.0216055.CrossRefPubMedPubMedCentral

27.

Tohme S, Yazdani HO, Al-Khafaji AB, Chidi AP, Loughran P, Mowen K et al. Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress. Cancer research. 2016;76(6):1367-80. doi:https://doi.org/10.1158/0008-5472.Can-15-1591.CrossRefPubMedPubMedCentral

28.

Cools-Lartigue J, Spicer J, McDonald B, Gowing S, Chow S, Giannias B et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. The Journal of clinical investigation. 2013;123(8):3446-58. doi:https://doi.org/10.1172/jci67484.CrossRefPubMedCentral

29.

Eustache JH, Tohme S, Milette S, Rayes RF, Tsung A, Spicer JD. Casting a wide net on surgery: the central role of neutrophil extracellular traps. Annals of surgery. 2020;272(2):277-83. doi:https://doi.org/10.1097/sla.0000000000003586.CrossRefPubMed

30.

Qi H, Yang S, Zhang L. Neutrophil extracellular traps and endothelial dysfunction in atherosclerosis and thrombosis. Front Immunol. 2017;8:928. doi:https://doi.org/10.3389/fimmu.2017.00928.CrossRefPubMedPubMedCentral

31.

Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nature reviews Cancer. 2008;8(8):618-31. doi:https://doi.org/10.1038/nrc2444.CrossRefPubMed

32.

Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nature reviews Cancer. 2013;13(11):759-71. doi:https://doi.org/10.1038/nrc3611.CrossRefPubMed

33.

Kim-Fuchs C, Le CP, Pimentel MA, Shackleford D, Ferrari D, Angst E et al. Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain Behav Immun. 2014;40:40-7. doi:https://doi.org/10.1016/j.bbi.2014.02.019.CrossRefPubMedPubMedCentral

34.

Le CP, Nowell CJ, Kim-Fuchs C, Botteri E, Hiller JG, Ismail H et al. Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination. Nat Commun. 2016;7:10634. doi:https://doi.org/10.1038/ncomms10634.CrossRefPubMedPubMedCentral

35.

Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer research. 2010;70(18):7042-52. doi:https://doi.org/10.1158/0008-5472.Can-10-0522.CrossRefPubMedPubMedCentral

36.

Martin AN, Kerwin MJ, Turrentine FE, Bauer TW, Adams RB, Stukenborg GJ et al. Blood transfusion is an independent predictor of morbidity and mortality after hepatectomy. The Journal of surgical research. 2016;206(1):106-12. doi:https://doi.org/10.1016/j.jss.2016.07.013.CrossRefPubMedPubMedCentral

37.

Ejaz A, Spolverato G, Kim Y, Margonis GA, Gupta R, Amini N et al. Impact of blood transfusions and transfusion practices on long-term outcome following hepatopancreaticobiliary surgery. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2015;19(5):887-96. doi:https://doi.org/10.1007/s11605-015-2776-5.CrossRef

38.

Murthy BL, Thomson CS, Dodwell D, Shenoy H, Mikeljevic JS, Forman D et al. Postoperative wound complications and systemic recurrence in breast cancer. British journal of cancer. 2007;97(9):1211-7. doi:https://doi.org/10.1038/sj.bjc.6604004.CrossRefPubMedPubMedCentral

39.

Bashir Mohamed K, Hansen CH, Krarup PM, Fransgård T, Madsen MT, Gögenur I. The impact of anastomotic leakage on recurrence and long-term survival in patients with colonic cancer: A systematic review and meta-analysis. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2020;46(3):439-47. doi:https://doi.org/10.1016/j.ejso.2019.10.038.CrossRef

40.

Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, Kowalska MA et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer research. 2004;64(23):8613-9. doi:https://doi.org/10.1158/0008-5472.Can-04-2078.CrossRefPubMed

41.

Kaltenmeier CT, Yazdani H, van der Windt D, Molinari M, Geller D, Tsung A et al. Neutrophil extracellular traps as a novel biomarker to predict recurrence-free and overall survival in patients with primary hepatic malignancies. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2020. https://doi.org/10.1016/j.hpb.2020.06.012.

42.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. doi:https://doi.org/10.1371/journal.pmed.1000100.CrossRefPubMedPubMedCentral

43.

Makito K, Matsui H, Fushimi K, Yasunaga H. Volatile versus total intravenous anesthesia for cancer prognosis in patients having digestive cancer surgery. Anesthesiology. 2020;133(4):764-73. doi:https://doi.org/10.1097/aln.0000000000003440.CrossRefPubMed

44.

Iwasaki M, Zhao H, Jaffer T, Unwith S, Benzonana L, Lian Q et al. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget. 2016;7(18):26042-56. doi:https://doi.org/10.18632/oncotarget.8304.CrossRefPubMedPubMedCentral

45.

Huang H, Benzonana LL, Zhao H, Watts HR, Perry NJ, Bevan C et al. Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. British journal of cancer. 2014;111(7):1338-49. doi:https://doi.org/10.1038/bjc.2014.426.CrossRefPubMedPubMedCentral

46.

Benzonana LL, Perry NJ, Watts HR, Yang B, Perry IA, Coombes C et al. Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro. Anesthesiology. 2013;119(3):593-605. doi:https://doi.org/10.1097/ALN.0b013e31829e47fd.CrossRefPubMed

47.

Luo X, Zhao H, Hennah L, Ning J, Liu J, Tu H et al. Impact of isoflurane on malignant capability of ovarian cancer in vitro. Br J Anaesth. 2015;114(5):831-9. doi:https://doi.org/10.1093/bja/aeu408.CrossRefPubMed

48.

Zhu M, Li M, Zhou Y, Dangelmajer S, Kahlert UD, Xie R et al. Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo. Br J Anaesth. 2016;116(6):870-7. doi:https://doi.org/10.1093/bja/aew124.CrossRefPubMed

49.

Chen RM, Chen TG, Chen TL, Lin LL, Chang CC, Chang HC et al. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Ann N Y Acad Sci. 2005;1042:262-71. doi:https://doi.org/10.1196/annals.1338.030.CrossRefPubMed

50.

Wu KC, Yang ST, Hsia TC, Yang JS, Chiou SM, Lu CC et al. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. Anticancer research. 2012;32(11):4833-42.PubMed

51.

Mammoto T, Mukai M, Mammoto A, Yamanaka Y, Hayashi Y, Mashimo T et al. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett. 2002;184(2):165-70. doi:https://doi.org/10.1016/s0304-3835(02)00210-0.CrossRefPubMed

52.

Chen MS, Lin WC, Yeh HT, Hu CL, Sheu SM. Propofol specifically reduces PMA-induced neutrophil extracellular trap formation through inhibition of p-ERK and HOCl. Life Sci. 2019;221:178-86. doi:https://doi.org/10.1016/j.lfs.2019.02.030.CrossRefPubMed

53.

Meier A, Chien J, Hobohm L, Patras KA, Nizet V, Corriden R. Inhibition of human neutrophil extracellular trap (NET) production by propofol and lipid emulsion. Front Pharmacol. 2019;10:323. doi:https://doi.org/10.3389/fphar.2019.00323.CrossRefPubMedPubMedCentral

54.

Bar-Yosef S, Melamed R, Page GG, Shakhar G, Shakhar K, Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology. 2001;94(6):1066-73. doi:https://doi.org/10.1097/00000542-200106000-00022.CrossRefPubMed

55.

Elena G, Amerio N, Ferrero P, Bay ML, Valenti J, Colucci D et al. Effects of repetitive sevoflurane anaesthesia on immune response, select biochemical parameters and organ histology in mice. Lab Anim. 2003;37(3):193-203. doi:https://doi.org/10.1258/002367703766453038.CrossRefPubMed

56.

Inada T, Hirota K, Shingu K. Intravenous anesthetic propofol suppresses prostaglandin E2 and cysteinyl leukotriene production and reduces edema formation in arachidonic acid-induced ear inflammation. J Immunotoxicol. 2015;12(3):261-5. doi:https://doi.org/10.3109/1547691x.2014.938874.CrossRefPubMed

57.

Desmond F, McCormack J, Mulligan N, Stokes M, Buggy DJ. Effect of anaesthetic technique on immune cell infiltration in breast cancer: a follow-up pilot analysis of a prospective, randomised, investigator-masked study. Anticancer research. 2015;35(3):1311-9.PubMed

58.

Inada T, Yamanouchi Y, Jomura S, Sakamoto S, Takahashi M, Kambara T et al. Effect of propofol and isoflurane anaesthesia on the immune response to surgery. Anaesthesia. 2004;59(10):954-9. doi:https://doi.org/10.1111/j.1365-2044.2004.03837.x.CrossRefPubMed

59.

Ke JJ, Zhan J, Feng XB, Wu Y, Rao Y, Wang YL. A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy. Anaesth Intensive Care. 2008;36(1):74-8. doi:https://doi.org/10.1177/0310057x0803600113.CrossRefPubMed

60.

Ferrell JK, Cattano D, Brown RE, Patel CB, Karni RJ. The effects of anesthesia on the morphoproteomic expression of head and neck squamous cell carcinoma: a pilot study. Translational research : the journal of laboratory and clinical medicine. 2015;166(6):674-82. doi:https://doi.org/10.1016/j.trsl.2015.09.001.CrossRef

61.

Liu S, Gu X, Zhu L, Wu G, Zhou H, Song Y et al. Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer. Medicine. 2016;95(49):e5479. doi:https://doi.org/10.1097/md.0000000000005479.CrossRefPubMedPubMedCentral

62.

Yan T, Zhang GH, Wang BN, Sun L, Zheng H. Effects of propofol/remifentanil-based total intravenous anesthesia versus sevoflurane-based inhalational anesthesia on the release of VEGF-C and TGF-β and prognosis after breast cancer surgery: a prospective, randomized and controlled study. BMC anesthesiology. 2018;18(1):131. doi:https://doi.org/10.1186/s12871-018-0588-3.CrossRefPubMedPubMedCentral

63.

Wu ZF, Lee MS, Wong CS, Lu CH, Huang YS, Lin KT et al. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in colon cancer surgery. Anesthesiology. 2018;129(5):932-41. doi:https://doi.org/10.1097/aln.0000000000002357.CrossRefPubMed

64.

Lai HC, Lee MS, Lin C, Lin KT, Huang YH, Wong CS et al. Propofol-based total intravenous anaesthesia is associated with better survival than desflurane anaesthesia in hepatectomy for hepatocellular carcinoma: a retrospective cohort study. Br J Anaesth. 2019;123(2):151-60. doi:https://doi.org/10.1016/j.bja.2019.04.057.CrossRefPubMedPubMedCentral

65.

Lai HC, Lee MS, Lin KT, Chan SM, Chen JY, Lin YT et al. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in intrahepatic cholangiocarcinoma surgery. Medicine. 2019;98(51):e18472. doi:https://doi.org/10.1097/md.0000000000018472.CrossRefPubMedPubMedCentral

66.

Kim MH, Kim DW, Kim JH, Lee KY, Park S, Yoo YC. Does the type of anesthesia really affect the recurrence-free survival after breast cancer surgery? Oncotarget. 2017;8(52):90477-87. doi:https://doi.org/10.18632/oncotarget.21014.CrossRefPubMedPubMedCentral

67.

Oh TK, Kim K, Jheon S, Lee J, Do SH, Hwang JW et al. Long-term oncologic outcomes for patients undergoing volatile versus intravenous anesthesia for non-small cell lung cancer surgery: a retrospective propensity matching analysis. Cancer control : journal of the Moffitt Cancer Center. 2018;25(1):1073274818775360. doi:https://doi.org/10.1177/1073274818775360.CrossRef

68.

Oh TK, Kim HH, Jeon YT. Retrospective analysis of 1-year mortality after gastric cancer surgery: total intravenous anesthesia versus volatile anesthesia. Acta anaesthesiologica Scandinavica. 2019;63(9):1169-77. doi:https://doi.org/10.1111/aas.13414.CrossRefPubMed

69.

Sessler DI, Pei L, Huang Y, Fleischmann E, Marhofer P, Kurz A et al. Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial. Lancet. 2019;394(10211):1807-15. doi:https://doi.org/10.1016/s0140-6736(19)32313-x.CrossRefPubMed

70.

Tavare AN, Perry NJ, Benzonana LL, Takata M, Ma D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. International journal of cancer Journal international du cancer. 2012;130(6):1237-50. doi:https://doi.org/10.1002/ijc.26448.CrossRefPubMed

71.

Huitink JM, Heimerikxs M, Nieuwland M, Loer SA, Brugman W, Velds A et al. Volatile anesthetics modulate gene expression in breast and brain tumor cells. Anesthesia and analgesia. 2010;111(6):1411-5. doi:https://doi.org/10.1213/ANE.0b013e3181fa3533.CrossRefPubMed

72.

Markovic-Bozic J, Karpe B, Potocnik I, Jerin A, Vranic A, Novak-Jankovic V. Effect of propofol and sevoflurane on the inflammatory response of patients undergoing craniotomy. BMC anesthesiology. 2016;16:18. doi:https://doi.org/10.1186/s12871-016-0182-5.CrossRefPubMedPubMedCentral

73.

Stollings LM, Jia LJ, Tang P, Dou H, Lu B, Xu Y. Immune modulation by volatile anesthetics. Anesthesiology. 2016;125(2):399-411. doi:https://doi.org/10.1097/aln.0000000000001195.CrossRefPubMed

74.

Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesthesia and analgesia. 2003;97(5):1331-9. doi:https://doi.org/10.1213/01.ane.0000082995.44040.07.CrossRefPubMed

75.

Lee JH, Kang SH, Kim Y, Kim HA, Kim BS. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean journal of anesthesiology. 2016;69(2):126-32. doi:https://doi.org/10.4097/kjae.2016.69.2.126.CrossRefPubMedPubMedCentral

76.

Zheng X, Wang Y, Dong L, Zhao S, Wang L, Chen H et al. Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study. OncoTargets and therapy. 2018;11:1141-8. doi:https://doi.org/10.2147/ott.S156792.CrossRefPubMedPubMedCentral

77.

Lai HC, Lee MS, Lin KT, Huang YH, Chen JY, Lin YT et al. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in robot-assisted radical prostatectomy. PloS one. 2020;15(3):e0230290. doi:https://doi.org/10.1371/journal.pone.0230290.CrossRefPubMedPubMedCentral

78.

Lee CJ, Tai YT, Lin YL, Chen RM. Molecular mechanisms of propofol-involved suppression of no biosynthesis and inducible iNOS gene expression in LPS-stimulated macrophage-like raw 264.7 cells. Shock (Augusta, Ga). 2010;33(1):93-100. doi:https://doi.org/10.1097/SHK.0b013e3181a6eaf5.CrossRef

79.

Chang CY, Wu MY, Chien YJ, Su IM, Wang SC, Kao MC. Anesthesia and long-term oncological outcomes: a systematic review and meta-analysis. Anesthesia and analgesia. 2020. https://doi.org/10.1213/ane.0000000000005237.

Titel: Association Between Anesthesia Delivered During Tumor Resection and Cancer Survival: a Systematic Review of a Mixed Picture with Constant Themes
verfasst von: Luke V. Selby
Ana Fernandez-Bustamante
Aslam Ejaz
Ana Gleisner
Timothy M. Pawlik
David J. Douin
Publikationsdatum: 07.06.2021
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Surgery / Ausgabe 8/2021
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-021-05037-7

Neu im Fachgebiet Chirurgie

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Association Between Anesthesia Delivered During Tumor Resection and Cancer Survival: a Systematic Review of a Mixed Picture with Constant Themes